Hardy S - Search Results

1

Identification of function-regulating antibodies targeting the receptor protein tyrosine phosphatase sigma ectodomain.

Wu CL, Hardy S, Aubry I, Landry M, Haggarty A, Saragovi HU, Tremblay ML. Wu CL, et al. Among authors: hardy s. PLoS One. 2017 May 30;12(5):e0178489. doi: 10.1371/journal.pone.0178489. eCollection 2017. PLoS One. 2017. PMID: 28558026 Free PMC article.

2

Inhibition of PRL-2·CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth.

Kostantin E, Hardy S, Valinsky WC, Kompatscher A, de Baaij JH, Zolotarov Y, Landry M, Uetani N, Martínez-Cruz LA, Hoenderop JG, Shrier A, Tremblay ML. Kostantin E, et al. Among authors: hardy s. J Biol Chem. 2016 May 13;291(20):10716-25. doi: 10.1074/jbc.M115.705863. Epub 2016 Mar 11. J Biol Chem. 2016. PMID: 26969161 Free PMC article.

3

Protein tyrosine phosphatome metabolic screen identifies TC-PTP as a positive regulator of cancer cell bioenergetics and mitochondrial dynamics.

Vinette V, Aubry I, Insull H, Uetani N, Hardy S, Tremblay ML. Vinette V, et al. Among authors: hardy s. FASEB J. 2021 Jul;35(7):e21708. doi: 10.1096/fj.202100207R. FASEB J. 2021. PMID: 34169549

4

Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse.

Hassan SW, Doody KM, Hardy S, Uetani N, Cournoyer D, Tremblay ML. Hassan SW, et al. Among authors: hardy s. PLoS One. 2010 Jan 25;5(1):e8868. doi: 10.1371/journal.pone.0008868. PLoS One. 2010. PMID: 20111595 Free PMC article.

5

Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.

Hardy S, Wong NN, Muller WJ, Park M, Tremblay ML. Hardy S, et al. Cancer Res. 2010 Nov 1;70(21):8959-67. doi: 10.1158/0008-5472.CAN-10-2041. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841483

6

Inside the human cancer tyrosine phosphatome.

Julien SG, Dubé N, Hardy S, Tremblay ML. Julien SG, et al. Among authors: hardy s. Nat Rev Cancer. 2011 Jan;11(1):35-49. doi: 10.1038/nrc2980. Nat Rev Cancer. 2011. PMID: 21179176 Review.

7

Impact of oncogenic protein tyrosine phosphatases in cancer.

Hardy S, Julien SG, Tremblay ML. Hardy S, et al. Anticancer Agents Med Chem. 2012 Jan;12(1):4-18. doi: 10.2174/187152012798764741. Anticancer Agents Med Chem. 2012. PMID: 21707506 Review.

8

PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer.

Lessard L, Labbé DP, Deblois G, Bégin LR, Hardy S, Mes-Masson AM, Saad F, Trotman LC, Giguère V, Tremblay ML. Lessard L, et al. Among authors: hardy s. Cancer Res. 2012 Mar 15;72(6):1529-37. doi: 10.1158/0008-5472.CAN-11-2602. Epub 2012 Jan 26. Cancer Res. 2012. PMID: 22282656 Free PMC article.

9

Protein tyrosine phosphatases in cancer: friends and foes!

Labbé DP, Hardy S, Tremblay ML. Labbé DP, et al. Among authors: hardy s. Prog Mol Biol Transl Sci. 2012;106:253-306. doi: 10.1016/B978-0-12-396456-4.00009-2. Prog Mol Biol Transl Sci. 2012. PMID: 22340721 Review.

10

The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis.

Hardy S, Uetani N, Wong N, Kostantin E, Labbé DP, Bégin LR, Mes-Masson A, Miranda-Saavedra D, Tremblay ML. Hardy S, et al. Oncogene. 2015 Feb 19;34(8):986-95. doi: 10.1038/onc.2014.33. Epub 2014 Mar 17. Oncogene. 2015. PMID: 24632616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

928 results

Search Page

Filters